Ondine Biomedical Inc
LSE:OBI
Balance Sheet
Balance Sheet Decomposition
Ondine Biomedical Inc
Ondine Biomedical Inc
Balance Sheet
Ondine Biomedical Inc
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
5
|
5
|
1
|
1
|
1
|
30
|
13
|
3
|
10
|
|
| Cash Equivalents |
3
|
5
|
5
|
1
|
1
|
1
|
30
|
13
|
3
|
10
|
|
| Short-Term Investments |
12
|
11
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
1
|
1
|
1
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
|
| Total Current Assets |
17
|
18
|
12
|
2
|
2
|
2
|
34
|
15
|
5
|
12
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
17
N/A
|
18
+7%
|
13
-30%
|
3
-77%
|
3
-11%
|
3
-3%
|
34
+1 247%
|
17
-51%
|
6
-65%
|
13
+124%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
2
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
2
|
2
|
1
|
2
|
4
|
4
|
3
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+151%
|
2
+15%
|
2
-26%
|
1
-17%
|
2
+68%
|
4
+99%
|
5
+10%
|
4
-26%
|
6
+63%
|
|
| Equity | |||||||||||
| Common Stock |
34
|
45
|
51
|
51
|
55
|
56
|
235
|
235
|
240
|
263
|
|
| Retained Earnings |
19
|
31
|
44
|
54
|
59
|
62
|
216
|
234
|
248
|
266
|
|
| Additional Paid In Capital |
1
|
2
|
3
|
4
|
5
|
6
|
11
|
11
|
11
|
11
|
|
| Total Equity |
17
N/A
|
17
+1%
|
11
-35%
|
1
-88%
|
1
-4%
|
0
-78%
|
30
+10 522%
|
12
-61%
|
2
-82%
|
7
+230%
|
|
| Total Liabilities & Equity |
17
N/A
|
18
+7%
|
13
-30%
|
3
-77%
|
3
-11%
|
3
-3%
|
34
+1 247%
|
17
-51%
|
6
-65%
|
13
+124%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3
|
4
|
4
|
4
|
7
|
8
|
195
|
195
|
227
|
404
|
|